Jacqueline Royce, DO
Plastic Surgery · Bradenton, FLNPI 1700964798
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.8%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 49.9% of the total. Reporting peaked in 2023 at $1,601 and has fallen 91.8% since, to $131 in 2025.
Across 40 payments — averaging $88.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- AbbVie$962
- Mentor Worldwide LLC$276
- Convatec Inc.$131
- Sientra, Inc.$89
- Merz North America, Inc.$72
- plus $240 from 8 others
What the payments were for
- Travel & lodging$1,09331%
- Food & beverage$1,69048%
- Gifts$75021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 9 | $1,763 |
| AbbVie(2 entities) | 10 | $962 |
| Mentor Worldwide LLC | 4 | $276 |
| Convatec Inc. | 3 | $131 |
| Sientra, Inc. | 2 | $89 |
| Merz North America, Inc. | 2 | $72 |
| Integra Lifesciences Corporation | 2 | $53 |
| Merck | 2 | $42 |
| Organogenesis Inc. | 1 | $36 |
| Stability Biologics, LLC | 1 | $28 |
| Avanos Medical | 1 | $27 |
| TELA Bio, Inc. | 1 | $19 |
| Innocoll Pharmaceuticals Limited | 1 | $19 |
| Ocular Therapeutix, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,533 in reported general payments places this provider in the 60th percentile of 456 plastic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zafirlukast | 11 | $634 |
| Cephalexin | 98 | $585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $370 |
| Clindamycin Hcl | 18 | $142 |
| Ondansetron OdtOndansetron | 20 | $83 |
| Diazepam | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Bradenton
- Michael VanvlietBradenton$119K
- Melinda Lacerna KimbrellBradenton$47K
- Robert RehnkeSt Petersburg$6.1M
- Anthony DardanoBoca Raton$586K
- Devinder SinghMiami$407K
- Brad HermanSouth Miami$293K
- Melanie Aya-AyTampa$283K
- Gloria YeeMiami$268K
- Daniel KappWest Palm Beach$252K
- Essie Kueberuwa YatesWeston$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.